These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15668623)

  • 21. Lack of effects of emulsified propofol ('Diprivan') on vecuronium pharmacodynamics--preliminary results in man.
    De Grood PM; Van Egmond J; Van De Wetering M; Van Beem HB; Booij LH; Crul JF
    Postgrad Med J; 1985; 61 Suppl 3():28-30. PubMed ID: 2865718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acceleromyography and mechanomyography for establishing potency of neuromuscular blocking agents: a randomized-controlled trial.
    Claudius C; Skovgaard LT; Viby-Mogensen J
    Acta Anaesthesiol Scand; 2009 Apr; 53(4):449-54. PubMed ID: 19317862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Influence of epidural lidocaine injection on vecuronium-induced neuromuscular blockade].
    Munakata K; Suzuki T; Watanabe N; Nagai H; Kakishita M; Saeki S; Ogawa S
    Masui; 2004 Dec; 53(12):1377-80. PubMed ID: 15682798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of the relaxant effects of pancuronium, rocuronium, vecuronium and mivacurium on rat thoracic aorta.
    Gursoy S; Bagcivan I; Durmus N; Kaygusuz K; Kol IO; Yildirim S; Mimaroglu C
    Eur J Anaesthesiol; 2009 Feb; 26(2):155-9. PubMed ID: 19142091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis.
    Woloszczuk-Gebicka B; Wyska E; Grabowski T
    Paediatr Anaesth; 2007 Jul; 17(7):637-46. PubMed ID: 17564645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
    White PF; Tufanogullari B; Sacan O; Pavlin EG; Viegas OJ; Minkowitz HS; Hudson ME
    Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision.
    Fuchs-Buder T; Claudius C; Skovgaard LT; Eriksson LI; Mirakhur RK; Viby-Mogensen J;
    Acta Anaesthesiol Scand; 2007 Aug; 51(7):789-808. PubMed ID: 17635389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of gender on the course of neuromuscular block following a single bolus dose of cisatracurium or rocuronium.
    Adamus M; Gabrhelik T; Marek O
    Eur J Anaesthesiol; 2008 Jul; 25(7):589-95. PubMed ID: 18405411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial.
    Pühringer FK; Rex C; Sielenkämper AW; Claudius C; Larsen PB; Prins ME; Eikermann M; Khuenl-Brady KS
    Anesthesiology; 2008 Aug; 109(2):188-97. PubMed ID: 18648227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rocuronium 0.3 mg x kg-1 (ED95) induces a normal peak effect but an altered time course of neuromuscular block in patients with Duchenne's muscular dystrophy.
    Muenster T; Schmidt J; Wick S; Forst J; Schmitt HJ
    Paediatr Anaesth; 2006 Aug; 16(8):840-5. PubMed ID: 16884467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sedation after intubation using etomidate and a long-acting neuromuscular blocker.
    Kendrick DB; Monroe KW; Bernard DW; Tofil NM
    Pediatr Emerg Care; 2009 Jun; 25(6):393-6. PubMed ID: 19458564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia.
    Rex C; Wagner S; Spies C; Scholz J; Rietbergen H; Heeringa M; Wulf H
    Anesthesiology; 2009 Jul; 111(1):30-5. PubMed ID: 19512873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of SZ1677, a new non-depolarizing steroidal neuromuscular blocking drug, and rocuronium on two laryngeal muscles and the anterior tibial muscle in guinea pigs.
    Michalek-Sauberer A; Nicolakis EM; Vizi ES; Gilly H
    Acta Anaesthesiol Scand; 2006 Apr; 50(4):481-7. PubMed ID: 16548861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is time to peak effect of neuromuscular blocking agents dependent on dose? Testing the concept of buffered diffusion.
    Proost JH; Houwertjes MC; Wierda JM
    Eur J Anaesthesiol; 2008 Jul; 25(7):572-80. PubMed ID: 18400136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium.
    Maybauer DM; Geldner G; Blobner M; Pühringer F; Hofmockel R; Rex C; Wulf HF; Eberhart L; Arndt C; Eikermann M
    Anaesthesia; 2007 Jan; 62(1):12-7. PubMed ID: 17156221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of time of day on the duration of neuromuscular blockade elicited by rocuronium.
    Cheeseman JF; Merry AF; Pawley MD; de Souza RL; Warman GR
    Anaesthesia; 2007 Nov; 62(11):1114-20. PubMed ID: 17924891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuromuscular transmission: new concepts and agents.
    de Boer HD
    J Crit Care; 2009 Mar; 24(1):36-42. PubMed ID: 19272537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intubation conditions with low dose rocuronium under sevoflurane induction for children.
    Hung CT; Shih MH; Shih CJ; Liou SC; Kau YC; Chan C; Wong KM
    Chang Gung Med J; 2005 Mar; 28(3):174-9. PubMed ID: 15945324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure.
    Robertson EN; Driessen JJ; Vogt M; De Boer H; Scheffer GJ
    Eur J Anaesthesiol; 2005 Dec; 22(12):929-32. PubMed ID: 16318664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.